SyndactylyDISTSSEQUELONCT07596862
Remote Assesment of Functional Sequelae in Patients Operated for Congenital Syndactyly
An observational study of Syndactyly, run by University Hospital, Lille at 1 site in France.
Trial summary
The aim of th study is to evaluate patients who have been operated for congenital syndactylies. The surgical technique has evolved, and the donnor site for the total skin graft is not the same than 10 years ago. Read more about this study
- Who is it for?
- Ages 2 to 19 years
- Conditions the study is for
- Syndactyly
- What is being tested?
- Consultation
- How many people
- 37 participants
- Where
- 1 siteFrance
- Study dates
- 7 Dec 2023to 30 Jun 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 2 to 19 years
- All sexes
- No healthy volunteers
- Child, Adult
Study population: Il s'agit d'une cohorte de patients opérés d'une syndactylie congénitale des doigts longs. On étudie ici la rétraction commissurale et les séquelles fonctionnelles et esthétiques, avec greffe de peau totale prélevée au niveau du pli du poignet.
Who may be able to join
- operated between 2005 and 2019 at Lille University Hospital.
- born between 2003 and 2020.
- With congenital syndactyly (ies) of the upper limb.
- Syndromic or non syndromic congenital syndactyly of the upper of the long fingers.
Who cannot join
- Patients operated on before 2005 or after 2020
- Acquired syndactyly (post-traumatic)
- Syndactyly (ies) of the lower limb.
- congenital syndactyly of the first webspace
- Impossible to obtain consent from parents or patients or refusal
- Unable to travel to Lille University Hospital for the consultation.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Evaluation of the Gilbert Dorsal Commissural Flap in the Managment of Congenital Syndactylies
The aim of th study is to evaluate patients who have been operated for congenital syndactylies. The surgical technique has evolved, and the donnor site for the total skin graft is not the same than 10 years ago. Furthermore, the investigators want to evaluate the function of the hand and the evolution of the operated web space. The patient is examined in consultation by the same doctor, the investigator list complications and evolution of the hand. the investigators also ask the patient and his parents about the satisfaction of the surgery.
- Conditions
- Syndactyly
- Being tested
- Consultation
- Keywords
- Syndactyly, congenital hand deformity, webspace, Withey score, Vancouver scar scale
- Medical subject headings
- Syndactyly, Hand Deformities, Congenital
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ConsultationOther
Patients will be called in for consultation in the CHU de Lille to be examined.
| Study group | Role | What they receive |
|---|---|---|
| Consultation | Patients will be called in for consultation in the CHU de Lille to be examined. Receives: Other: Consultation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Study of the retraction of the webspace with Withey scale
Measured: From 4 years to 18 years after the surgery
Secondary outcomes (1)
Evaluation of the scars with Vancouver scale.
Measured: From 4 years to 18 years after the surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 May 2026
- Study start7 Dec 2023
- Primary completion1 Dec 2024
- Study completion30 Jun 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for SyndactylyStudies of the same condition, open and under way.
- More trials run by University Hospital, LilleThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 37 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Hospital, Lille
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07596862
- Sponsor's protocol ID
- 2020_88
- Other IDs
- 2021-A02023-38
- Acronym
- DISTSSEQUELO
- Status last verified
- May 2026
- First submitted
- 13 Nov 2023
- Last updated
- 19 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 19 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of the Gilbert Dorsal Commissural Flap in the Managment of Congenital Syndactylies
- ClinicalTrials.gov ID
- NCT07596862
- Acronym / sponsor ID
- DISTSSEQUELO / 2020_88
- Conditions
- Syndactyly
- Keywords
- Syndactyly, congenital hand deformity, webspace, Withey score, Vancouver scar scale
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 37 participants (actual)
- Lead sponsor
- University Hospital, LilleUniversity, hospital or other
- Study start
- 7 Dec 2023 (actual)
- Primary completion
- 1 Dec 2024 (actual)
- Study completion
- 30 Jun 2025 (actual)
- First posted
- 19 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of th study is to evaluate patients who have been operated for congenital syndactylies. The surgical technique has evolved, and the donnor site for the total skin graft is not the same than 10 years ago. Furthermore, the investigators want to evaluate the function of the hand and the evolution of the operated web space. The patient is examined in consultation by the same doctor, the investigator list complications and evolution of the hand. the investigators also ask the patient and his parents about the satisfaction of the surgery.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Consultation | – | Other: ConsultationPatients will be called in for consultation in the CHU de Lille to be examined. |
Who may qualify
- Ages
- 2 to 19 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
- Study population
- Il s'agit d'une cohorte de patients opérés d'une syndactylie congénitale des doigts longs. On étudie ici la rétraction commissurale et les séquelles fonctionnelles et esthétiques, avec greffe de peau totale prélevée au niveau du pli du poignet.
Key inclusion criteria (4 listed)
- operated between 2005 and 2019 at Lille University Hospital.
- born between 2003 and 2020.
- With congenital syndactyly (ies) of the upper limb.
- Syndromic or non syndromic congenital syndactyly of the upper of the long fingers.
Key exclusion criteria (6 listed)
- Patients operated on before 2005 or after 2020
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ConsultationPatients will be called in for consultation in the CHU de Lille to be examined. | Other | Consultation |
Primary outcome
Study of the retraction of the webspace with Withey scale
Time frame: From 4 years to 18 years after the surgery
1 secondary outcome
Evaluation of the scars with Vancouver scale.
Time frame: From 4 years to 18 years after the surgery
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 May 2026.
Related trials for Syndactyly
Active, not recruitingPhase 1
Safety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating FGFR2 Gene Alterations
Locally Advanced Cholangiocarcinoma, Intrahepatic Cholangiocarcinoma
RecruitingObservational study
ASO Treatment for Syndromic Craniosynostoses
Craniosynostoses, Crouzon Syndrome
RecruitingPhase 3
Futibatinib (TAS-120) in Patients With Advanced Biliary Tract Cancer
Biliary Tract Cancer
RecruitingPhase 1/2
A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1
Renal Cell Carcinoma Metastatic, Prostate Cancer Metastatic
Recruiting
Motiva Flora® Aesthetic Breast Recon® Clinical Study
Mammaplasty, Breast Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Syndactyly, run by University Hospital, Lille at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 19 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Study of the retraction of the webspace with Withey scale (time frame: From 4 years to 18 years after the surgery). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 May 2026.